60 Degrees Pharmaceuticals Announced That It Will Sponsor A Pilot Study Of Tafenoquine, The Active Molecule In Its U.s. Food And Drug Administration (Fda)-approved Human Malaria Prevention Medication, Arakoda, For The Treatment Of Babesiosis In Dogs
60 Degrees Pharmaceuticals Announced That It Will Sponsor A Pilot Study Of Tafenoquine, The Active Molecule In Its U.s. Food And Drug Administration (Fda)-approved Human Malaria Prevention Medication, Arakoda, For The Treatment Of Babesiosis In Dogs
60 Degrees Pharmicals宣佈將贊助一項他芬諾喹的試點研究，他芬諾喹是其經美國食品藥品監督管理局（Fda）批准的人類瘧疾預防藥物Arakoda中的活性分子，用於治療狗的巴貝斯蟲病
60 Degrees Pharmaceuticals Announced That It Will Sponsor A Pilot Study Of Tafenoquine, The Active Molecule In Its U.s. Food And Drug Administration (Fda)-approved Human Malaria Prevention Medication, Arakoda, For The Treatment Of Babesiosis In Dogs
60 Degrees Pharmicals宣佈將贊助一項他芬諾喹的試點研究，他芬諾喹是其經美國食品藥品監督管理局（Fda）批准的人類瘧疾預防藥物Arakoda中的活性分子，用於治療狗的巴貝斯蟲病
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。